Important Neurological Signs: Why Unresponsive Infant Seizures Point to HPP

Unresponsive seizures in infants can be alarming. When typical anti-seizure treatments fail, one rare but critical cause to consider is hypophosphatasia (HPP). In HPP, low activity of alkaline phosphatase disrupts vitamin B6 metabolism in the brain, leading to “vitamin B6 dependent seizures in babies.” Understanding this link helps families and clinicians act quickly to diagnose and manage a potentially life-threatening condition.

---

Recognizing Unresponsive Infant Seizures

Infant seizures may look very different from adult seizures. In HPP, most seizures:

• Do not respond to standard anticonvulsants (e.g., phenobarbital, benzodiazepines)
• Can occur multiple times a day, often without warning
• May appear as stiffening, jerking, eye deviation, or loss of muscle tone
• Sometimes present only as subtle staring or “listlessness”

Other signs that raise concern:

• Poor feeding or refusal to nurse
• Increased irritability or high-pitched crying
• Floppy muscle tone (hypotonia)
• Respiratory difficulties

Because these signs overlap with more common issues (infection, metabolic disturbances), it’s vital to note when seizures resist usual treatments. That failure to respond is a key neurological red flag.

---

What Is Hypophosphatasia (HPP)?

Hypophosphatasia is an inherited disorder caused by mutations in the ALPL gene. This gene encodes tissue-nonspecific alkaline phosphatase (TNSALP), an enzyme essential for bone mineralization and vitamin B6 (pyridoxine) metabolism.

Key points about HPP:

• It ranges from life-threatening (perinatal) to mild adult forms.
• Severe infantile HPP often presents within days to months of birth.
• Low enzyme activity leads to weak bones, respiratory compromise, and sometimes seizures.

In the most severe cases, symptoms include rickets-like bone changes, respiratory distress due to chest underdevelopment, and neurological crises.

---

How HPP Leads to Vitamin B6-Dependent Seizures

Vitamin B6 must be in its active form, pyridoxal 5′-phosphate (PLP), to support neurotransmitter production. In HPP:

1. TNSALP dysfunction prevents dephosphorylation of PLP to pyridoxal.
2. Pyridoxal cannot cross the blood-brain barrier efficiently.
3. Brain levels of PLP fall, impairing synthesis of GABA and other inhibitory neurotransmitters.
4. Resulting imbalance triggers recurrent, hard-to-control seizures.

Because seizures improve only when pyridoxine (vitamin B6) is administered intravenously or orally, they’re termed “vitamin B6 dependent seizures in babies.”

---

Diagnosing HPP in Babies with Seizures

Early diagnosis of HPP is critical. Clinicians rely on a combination of clinical, laboratory, imaging, and genetic data:

1. Clinical Suspicion

   • Refractory seizures within the first weeks of life
   • Signs of bone disease (soft, bowed bones; chest wall abnormalities)
   • Poor feeding, failure to thrive

2. Laboratory Tests

   • Serum alkaline phosphatase (ALP): low for age
   • Serum calcium and phosphate: often elevated phosphate
   • Elevated substrates: phosphoethanolamine in urine

3. Neurochemical Response

   • Rapid seizure control after pyridoxine or PLP infusion

4. Imaging

   • Skeletal X-rays: metaphyseal abnormalities, “beaded” ribs

5. Genetic Testing

   • ALPL gene sequencing confirms diagnosis

Because vitamin B6–responsive seizures can also occur in other disorders (e.g., pyridox(am)ine-5′-phosphate oxidase deficiency), correlating lab findings and genetics is essential.

---

Treatment and Management

Management of infantile HPP focuses on enzyme replacement, seizure control, and supportive care:

1. Enzyme Replacement Therapy (Asfotase Alfa)

   • Improves bone mineralization and overall survival
   • Dosed based on weight and clinical response

2. Vitamin B6 Supplementation

   • Pyridoxine or PLP doses titrated to stop seizures
   • Monitoring for potential toxicity (rare at therapeutic doses)

3. Symptom Management

   • Respiratory support (ventilation) if chest wall weakness is severe
   • Nutritional support for feeding difficulties
   • Physical therapy for hypotonia and developmental support

4. Multidisciplinary Care

   • Pediatric neurology, endocrinology, genetics, and orthopedics
   • Regular monitoring of bone growth, seizure control, and development

Early initiation of enzyme replacement, combined with vitamin B6 supplementation, can transform outcomes in infants with HPP.

---

When to Seek Medical Help

Any of the following signs in a baby warrant urgent medical evaluation:

• Repeated or prolonged seizures not stopping with first-line treatments
• Episodes of unresponsiveness or sudden limpness
• Severe feeding difficulties or weight loss
• Breathing problems, rapid breathing, or chest indrawing

If you notice these signs, don’t hesitate. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

---

Conclusion

Unresponsive seizures in infants can signal a rare but serious condition: hypophosphatasia leading to vitamin B6–dependent seizures in babies. Prompt recognition, laboratory testing, and genetic confirmation allow for targeted treatment—enzyme replacement and vitamin B6 supplementation—that can dramatically improve outcomes. Always discuss any concerning symptoms with a pediatrician or neurologist.

Speak to a doctor right away if your baby experiences life-threatening or serious symptoms.